CBIS Stock Chart & Historical Trading Data $CBIS Updated:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
166
CBIS Stock Chart & Historical Trading Data $CBIS Updated: 02-18-2017
Last Trade: 2/17/2017 4:04:00 PM
Last 0.114   +0.004 +3.60%
Open 0.110
Previous Close 0.110
Day High / Low 0.119 / 0.110
Year High / Low 0.246 / 0.009
Volume 30,818,141
Projected Volume 30818141 (46%)
# of Trades / Projected 2,633 / 2,633
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle BULLISH
Volatility Today LOW
Volatility Yesterday LOW
Price Relativity
From 40 Day High 88%
From 80 Day High 88%
From 150 Day High 88%
From 40 Day Low 283%
From 80 Day Low 382%
From 150 Day Low 847%
Pivot Analysis
Price Pivot $ 0.110
Day Resistance 1 $ 0.120
Day Support 1 $ 0.110
Day Resistance 2 $ 0.120
Day Support 2 $ 0.110
Consolidations
Short Term YES
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 66,871,010
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 39,188,920
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bearish
40 Day Trend bullish
100 Day Trend bullish
Stochastics bearish
RSI bearish
MACD bullish
Moving Average Indictors
15 Day Trend neutral
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today LOW
Volatility Index Yesterday LOW
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sarepta Therapeutics Faces Legal Scrutiny Amid Regulatory Challenges

Updated Category News Views 146

Legal Challenges for Sarepta Therapeutics The situation regarding Sarepta Therapeutics is becoming increasingly complex. Recently, a pending securities class action was initiated due to unsettling news about safety concerns linked to their medication, ELEVIDYS. This product aims to treat Duchenne muscular dystrophy, a severe condition affecting young boys. As the company...

Continue Reading
Enhancing Landscape Operations: LandCare's Partnership with Lytx+™

Updated Category News Views 81

LandCare Enhances Operational Efficiencies with Lytx+ LandCare, a leading commercial landscaping company in the nation, has made significant strides in its operations by adopting the innovative Lytx+™ solution in conjunction with Geotab. This collaboration aims to optimize fleet safety and management, ensuring that LandCare continues to thrive in a competitive...

Continue Reading
Grand Sierra Resort Launches Ambitious $1 Billion Arena Project

Updated Category News Views 292

Grand Sierra Resort Unveils Major Arena Development Grand Sierra Resort (GSR) has officially broken ground on a groundbreaking new arena, marking the first phase of an extensive $1 billion redevelopment project that is set to forever change the landscape of Reno. This ambitious undertaking is the largest private investment in the history of the region, signaling a bright...

Continue Reading
Saba Capital Management Adjusts Holdings in Eaton Vance Trust

Updated Category News Views 74

Saba Capital Management Modifies Its Holdings in Eaton Vance Trust Saba Capital Management, L.P., a significant player in the investment management sector, has recently garnered attention by adjusting its position in the Eaton Vance California Municipal Income Trust (NYSE: CEV). This strategic decision involved the sale of 44,367 shares, accumulating over $484,725 over...

Continue Reading
Key Insights on Treatt Plc's Market Dealing Activities

Updated Category News Views 127

Understanding the Amendment for Treatt Plc The recent amendment related to Treatt Plc has sparked interest in financial circles, especially among shareholders and market analysts. This document outlines public dealing disclosures from an exempt principal trader acting on behalf of a clientele, primarily concerning Treatt Plc, a prominent player in the flavor and fragrance...

Continue Reading